As components of the mCRM System, the devices are designed to work together wirelessly to coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy, provide rate-responsive bradycardia ...
BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...
While professional tennis is back, in various locales around the world, travel restrictions and stringent health and safety measures due to the coronavirus pandemic will continue to impact players for ...
It is being introduced for the first time, starting with the ATP 500 event in Rio de Janeiro next month. The trial was approved by the ATP Board last November, across the ATP 250 at an event to be ...
(RTTNews) - Boston Scientific Corp. (BSX) announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM System, the first modular cardiac rhythm management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results